Antibodies to prothrombin.
Research on antiphospholipid antibodies (aPL) and the thrombotic manifestations associated with these antibodies has grown since the description of anticardiolipin antibodies (aCL) by Harris and colleagues in the early 1980s. Antiprothrombin (aPT) antibodies are commonly detected by ELISA, using irradiated plates (aPT) or prothrombin in complex with phosphatidylserine (aPS/PT). Although aPT and/or aPS/PT are associated with antiphospholipid syndrome (APS) -related clinical features and these antibodies correlate with each other, aPT and aPS/PT belong to different populations of autoantibodies even though they can both be present in the same patient. Early studies suggested that these antibodies might be the antigenic target of lupus anticoagulant (LA) and their correlation and clinical significance is being investigated.
Lupus Research Unit, The Rayne Institute, King's College London, St Thomas' Hospital, London, UK. maria.bertolaccini@kcl.ac.uk
M L
ML
Bertolaccini
D001323:Autoantibodies / Q000276:immunology; D006801:Humans; D016682:Lupus Coagulation Inhibitor / Q000276:immunology; D011516:Prothrombin / Q000276:immunology*
D001323:Autoantibodies; D016682:Lupus Coagulation Inhibitor; D011516:Prothrombin